Ilex Medical (ILX) — Tangible Net Worth Ratio
Ilex Medical (ILX) has a Tangible Net Worth Ratio of 98.4% as of March 2026. This metric is calculated by deducting intangible assets (ILA10.50 Million) from net assets (ILA666.36 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore ILX net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Ilex Medical Tangible Net Worth Ratio (2008–2025)
This chart shows how Ilex Medical's Tangible Net Worth Ratio has changed across 18 annual periods from 2008 to 2025. As of March 2026, the ratio stands at 98.4%, reflecting net assets of ILA666.36 Million with intangible assets of ILA10.50 Million ILA. For live market cap and overall valuation, see market value of Ilex Medical.
Annual Tangible Net Worth Ratio for Ilex Medical (2008–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Ilex Medical from 2008 to 2025, covering 18 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Ilex Medical (ILX) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (ILA) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 98.3% | ILA684.71 Million | ILA11.95 Million | ILA992.74 Million | ▲ +0.9 pp |
| 2024 | 97.4% | ILA646.49 Million | ILA17.08 Million | ILA994.07 Million | ▲ +0.8 pp |
| 2023 | 96.6% | ILA623.51 Million | ILA21.18 Million | ILA1.02 Billion | ▲ +0.7 pp |
| 2022 | 95.9% | ILA613.10 Million | ILA25.10 Million | ILA899.18 Million | ▲ +0.4 pp |
| 2021 | 95.5% | ILA575.57 Million | ILA25.95 Million | ILA875.07 Million | ▲ +2.7 pp |
| 2020 | 92.8% | ILA443.54 Million | ILA31.77 Million | ILA779.25 Million | ▲ +4.3 pp |
| 2019 | 88.6% | ILA323.48 Million | ILA36.96 Million | ILA581.85 Million | ▲ +3.2 pp |
| 2018 | 85.4% | ILA293.49 Million | ILA42.99 Million | ILA533.38 Million | ▲ +4.2 pp |
| 2017 | 81.2% | ILA266.15 Million | ILA50.12 Million | ILA484.92 Million | ▲ +4.2 pp |
| 2016 | 76.9% | ILA244.51 Million | ILA56.36 Million | ILA487.56 Million | ▲ +5.6 pp |
| 2015 | 71.3% | ILA225.99 Million | ILA64.75 Million | ILA481.60 Million | ▲ +14.2 pp |
| 2014 | 57.1% | ILA204.60 Million | ILA87.75 Million | ILA506.54 Million | ▲ +1.4 pp |
| 2013 | 55.7% | ILA214.38 Million | ILA94.89 Million | ILA534.54 Million | ▲ +12.7 pp |
| 2012 | 43.0% | ILA259.96 Million | ILA148.12 Million | ILA600.69 Million | ▲ +15.4 pp |
| 2011 | 27.6% | ILA282.99 Million | ILA204.95 Million | ILA687.23 Million | ▼ -72.0 pp |
| 2010 | 99.5% | ILA120.80 Million | ILA571.00K | ILA191.62 Million | ▼ -0.3 pp |
| 2009 | 99.8% | ILA127.32 Million | ILA253.00K | ILA192.91 Million | ▲ +0.1 pp |
| 2008 | 99.7% | ILA109.44 Million | ILA277.00K | ILA170.14 Million | — |